Nebivolol Brand names: Bystolic

What is nebivolol used for?

From the label: indications and usage

INDICATIONS AND USAGE BYSTOLIC is a beta-adrenergic blocking agent indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. ( 1.1 ) 1.1 Hypertension BYSTOLIC is indicated for the treatment of hypertension, to lower blood pressure [see Clinical Studies ( 14.1 )]. BYSTOLIC may be used alone or in combination with other antihypertensive agents [see Drug Interactions ( 7 )]. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. […]

Conditions named in the indications of nebivolol's FDA labels, with every medicine labeled for each:

• High blood pressure

FDA pharmacologic class: beta-Adrenergic Blocker.

Is there a generic for nebivolol (Bystolic)?

The FDA approved the first generic nebivolol on April 16, 2015. 18 generic applications are approved; 13 of them carry a current (not discontinued) marketing status in Drugs@FDA; that status is not evidence that the generic is on sale. Drugs@FDA also holds 1 tentative approval: the FDA found the generic approvable, but patents or exclusivity keep it from final approval for now.

FDA's NDC Directory lists nebivolol from 23 labelers under a generic (ANDA) application and from 1 brand labeler. A listing means the company has registered the product for sale; it does not show that every pharmacy stocks it.

What do pharmacies pay for nebivolol (Bystolic)?

In CMS's NADAC survey of October 7, 2026, pharmacies paid $0.141 per Nebivolol 10 mg tablet, about the same as a year earlier. Prices per unit in the table differ many-fold by strength, form and brand, so compare like with like. The chart's scale runs from the lowest to the highest price shown, not from zero. NADAC is what retail pharmacies paid their wholesalers, per unit, in CMS's monthly survey; what a patient pays depends on insurance and the pharmacy.

Is nebivolol in shortage?

No nebivolol presentation is listed as in shortage in the FDA Drug Shortage Database (read October 8, 2026); its 16 records are all marked to be discontinued, the latest updated March 25, 2026. ASHP keeps a separate shortage list, which can differ.

Every nebivolol presentation in the FDA shortage database

Has nebivolol been recalled?

The FDA's Enforcement Report lists 6 recalls naming nebivolol since 2013: 0 Class I (the most serious), 5 Class II, 1 Class III; 2 still ongoing. 1 of them is by a firm that FDA's NDC Directory does not list as a maker of nebivolol and that holds no application for it in Drugs@FDA, such as compounding pharmacies or bulk-ingredient suppliers; the recall notice names the product recalled. A recall names products and lots, not every product of the medicine.

What does the nebivolol label say about other medicines?

The nebivolol label names 11 other medicines in its interaction, contraindication or warning sections. The labels of 4 other medicines name nebivolol. The sentences are the labels' own; a label lists what its studies and reports found, not every interaction.

Other labels that name nebivolol

• Desvenlafaxine
• Sertraline

Check nebivolol against other medicines

What do FAERS reports show for nebivolol?

The FDA Adverse Event Reporting System holds 33,555 reports that list nebivolol among the medicines taken, through July 30, 2026, each a report of something that happened, not proof the medicine caused it; 2,385 are coded as a death and 13,128 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is.

Reports received each year

• 2,700
• 2,148
• 3,069
• 2,829
• 2,432
• 1,978
• 2,364
• 2,151
• 2,111
• 1,872
• 1,042

• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

The most reported reactions

• Fatigue (named in the label)1,861
• Diarrhoea (named in the label)1,794
• Dyspnoea (named in the label)1,724
• Drug Ineffective (a use or a product term, not a reaction)1,627
• Nausea (named in the label)1,616
• Headache (named in the label)1,441
• Dizziness (named in the label)1,405
• Acute Kidney Injury1,293

Side effects: the label's list and every FAERS reaction

What else is labeled for the same conditions as nebivolol?

75 other medicines are given the same way (oral) and in the same FDA class as nebivolol or labeled mainly for the same use (high blood pressure), the same class first. High blood pressure lists all 88 medicines labeled for it, by any route. The first 8 are below. They are listed as records, not as substitutes: whether one can replace another is a prescriber's decision.

Every medicine labeled for the same conditions as nebivolol

How does nebivolol compare with medicines for the same use?

14 side-by-side pages set nebivolol beside a medicine whose label shares a use: approvals, generics, pharmacy cost, warnings and supply.

• Acebutolol
• Amlodipine
• Atenolol
• Bisoprolol
• Carvedilol
• Diltiazem
• Labetalol
• Lisinopril
• Losartan
• Metoprolol
• Olmesartan
• Propranolol
• Telmisartan
• Valsartan

What next?

Alternatives to nebivolol

75 medicines for the same use

Other beta blockers

the pharmacologic class, with prices and generics

Nebivolol side effects

the label's list beside FAERS reports

Nebivolol shortage record

every presentation, company and date

Check an interaction

what two or more labels say about each other